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Excessive responses to pattern-recognition recep-
tors are prevented by regulatory mechanisms that
affect the amounts and activities of the downstream
signaling proteins. We report that activation of the
transcription factor IRF3 by the ribonucleic acid
sensor RIG-I was restricted by caspase-8-mediated
cleavage of the RIP1 protein, which resulted in
conversion of RIP1 from a signaling enhancer to
a signaling inhibitor. The proteins RIP1 and cas-
pase-8 were recruited to the RIG-I complex after viral
infection and served antagonistic regulatory roles.
Conjugation of ubiquitin chains to RIP1 facilitated
assembly of the RIG-I complex, resulting in
enhanced phosphorylation of IRF3. However, the
ubiquitination of RIP1 also rendered it susceptible
to caspase-8-mediated cleavage that yielded an
inhibitory RIP1 fragment. The dependence of RIP1
cleavage on the samemolecular change as that facil-
itating RIG-I signaling allows for RIG-I signaling to be
restricted in its duration without compromising its
initial activation.
INTRODUCTION
Pattern-recognition receptors (PRRs) induce changes that, when
properly regulated, serve to eliminate the perturbants stimulating
them and thus regain homeostasis. When induced in excess,
however, these changes may themselves become deleterious.
The signaling activities of these receptors accordingly play
important roles, not only in defense against infectious agents
and in recovery from injury, but also in pathological manifesta-
tions of diseases. To safeguard against such harmful conse-
quences, the signaling complexes activated by these receptors
contain, in addition to proteins that initiate the signaling, proteins
that act to restrict its extent and duration.
The viral structural elements best known to stimulate PRRs
reside in their RNA and DNA (Kawai and Akira, 2006). Two
RNA helicases, RIG-I and MDA5, serve as cytoplasmic sensors
for viral RNA (Andrejeva et al., 2004; Kato et al., 2006; Yoneyama340 Immunity 34, 340–351, March 25, 2011 ª2011 Elsevier Inc.et al., 2004). These PRRs trigger the assembly of amitochondria-
associated protein complex that signals for activation of tran-
scription factors such as IRF3 and NF-kB. A number of the
proteins participating in this complex, including RIG-I and
MDA5 themselves, as well as two adaptor proteins recruited to
them, MAVS (also known as VISA, IPS-1, or Cardiff) (Kawai
et al., 2005; Meylan et al., 2005; Seth et al., 2005; Xu et al.,
2005) and MITA (also known as STING) (Ishikawa and Barber,
2008; Zhong et al., 2008), seem so far to be uniquely involved
in cellular responses to cytoplasmic foreign nucleic acids. This
complex also contains proteins that serve additional functions,
including several that participate in the induction of gene activa-
tion or cell death by receptors of the tumor necrosis factor (TNF)
receptor family (Balachandran et al., 2004; Kawai et al., 2005;
Michallet et al., 2008; Oganesyan et al., 2006; Saha et al.,
2006; Xu et al., 2005).
Both the initiation of these pathways and the arrest of their
signaling are dictated by induced posttranslational modifications
of the signaling proteins, such as phosphorylation or ubiquitina-
tion, which bring about association or dissociation of the
signaling proteins with other molecules or modulate their protea-
somal degradation. Dissociation of the signaling proteins is also
achieved via the synthesis of dedicated inhibitory proteins or of
nonfunctional splice variants of signaling proteins (reviewed in
Komuro et al., 2008). Here we described a mode of signaling
regulation that occurred through the interaction of two
proteins—RIP1 and caspase-8—that participate in signaling by
receptors of the TNF family (Wallach et al., 1999). We showed
that RIP1 promoted IRF3 activation downstream of the RIG-I
complex. However, this regulation was blocked upon the
cleavage of RIP1 by caspase-8. Moreover, RIP1, after being
cleaved by caspase-8, also acted as an inhibitor of the RIG-I
signaling. The temporal coordination of these antagonistic func-
tions of RIP1 was dictated by the conjugation of polyubiquitin
chains to RIP1. This conjugation both facilitated the assembly
of the RIG-I complex and was required for RIP1 cleavage by cas-
pase-8, linking maximal activation of signaling to its subsequent
termination.
Activation of caspase-8 by receptors of the TNF family medi-
ates induction of apoptotic cell death (Wallach et al., 1999).
However, caspase-8 also serves various nonapoptotic functions
(Ben Moshe et al., 2008). Our finding here points to a possible
general mode of action by which this protease serves nonapop-
totic functions.
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Caspase-8 Knockdown by a Caspase-8-siRNA-
Expressing Lentivirus Causes Arrest of Cell
Proliferation
While exploring the functional impact of caspase-8 deficiency by
knocking it down in human foreskin fibroblast FS11 and SV80
fibroblastoid cells via a lentivirus expressing a caspase-8 siRNA,
we noticed the arrest of cell proliferation (Figure 1A). Genome-
wide expression profiling revealed that this change correlated
with increased expression of various interferon (IFN)-response
genes (Figure 1B; Table S1 available online). The culture media
of the siRNA-treated cells exerted a growth-inhibitory effect
that was in part attributable to the presence of type I IFN (Figures
S1A and S1B). The presence of IFN also contributed to the
increase in expression of IFN-induced genes in these cells (Fig-
ure S1C). Consistently, the arrest of cell proliferation correlated
with enhanced phosphorylation of the transcription factor
STAT1, a hallmark of IFN activity. This enhancement was
preceded by dimerization of IRF3, a transcription factor-medi-
ating activation of IFN genes (Figure 1C). Knockdown of IRF3
prevented the arrest of cell proliferation (Figure 1D) as well as
the induction of STAT1 phosphorylation (Figure S1D) and of
IFN-induced genes (Figures S1E and S1F). When we applied
the caspase-8 siRNA lentivirus to cells expressing caspase-8
with a silent mutation that made it unresponsive to that siRNA,
the activation of both IRF3 and STAT1 (Figure 1C), as well as
the decrease in cell proliferation (Figure 1E), were abolished.
Also abolished was the late phase of increase in expression of
IFN-induced genes, although these cells still exhibited an early
mild increase in IFN-response genes by the vector (Figure S1G).
No increase in expression of IFN-induced genes or decrease in
cell proliferation was observed when synthetic oligonucleotide
siRNAs, rather than the lentivirus, were used to knock down cas-
pase-8 expression (data not shown). These findings suggested
that activation of IRF3 by the caspase-8 siRNA lentivirus reflects
the combined impact of a modest ability of the lentivirus to
trigger signaling for IRF3 activation and of potentiation of this
activation by the absence of caspase-8.
Caspase-8 Deficiency Facilitates Activation of IRF3,
but Not of NF-kB, by Cytoplasmic RNA
To validate the above interpretation that IRF3 activation is poten-
tiated in the absence of caspase-8, we compared the responses
of normal and caspase-8-deficient cells to synthetic and viral
RNA. In several cell lines of human and mouse origin, gene defi-
ciency (Casp8/) or knockdown of caspase-8 resulted in
enhanced induction of IRF3-dependent genes in response to
treatment with either Sendai virus (SeV) or transfected poly(I:C)
(Figure 2A). Luciferase reporter test for SeV-mediated increase
in transcriptional activity of IRF3-dependent promoter (contain-
ing an ISRE) showed that this activation was enhanced by
caspase-8 deficiency (Figure 2B). Consistently, absence of
caspase-8 was found to enhance both the virus-induced phos-
phorylation of IRF3 at serine 396 (Figure 2C; Figures S2A and
S2B) and IRF3 dimerization (Figure S2C). Similar effects on
IRF3 activation were observed with cells transfected with poly
(I:C) or infected by another RNA virus, vesicular stomatitis virus
(VSV; Figures S2D and S2E). In contrast, caspase-8 deficiencyhad no effect on the activation of NF-kB by SeV infection, as as-
sessed by the activation of NF-kB reporter construct (Figure 2B)
or induction of phosphorylation of IkB (Figure 2C; Figures S2A
and S2B). Thus, the activation of IRF3 by intracellular RNAs is
suppressed by caspase-8.
To examine the impact of caspase-8 deficiency on the cellular
response to viral RNA undermore physiologically relevant condi-
tions, we used mice with hepatocyte-specific deletion of cas-
pase-8 and injected them with SeV. Both phosphorylation and
nuclear translocation of IRF3 in the caspase-8-deficient hepato-
cytes were markedly enhanced and prolonged compared to
those in normal mice. In contrast, IRF3 phosphorylation in the
lungs was the same in the experimental and control groups
(Figure 2D).Caspase-8 and RIP1 Are Recruited to the RIG-I Complex
The above findings indicated that caspase-8 deficiency
enhances the activation of IRF3 by intracellular viral RNA. RIG-
I, a caspase activation and recruitment domain (CARD) contain-
ing RNA helicase, serves as the intracellular receptor initiating
the responses to a number of RNA viruses, including SeV and
VSV. As shown in Figures 3A and 3B and Figure S3A, infection
of cells with SeV induced association of caspase-8 with the
RIG-I complex, as reflected in coimmunoprecipitation of cas-
pase-8 with various components of this complex. RIP1, another
protein known to participate in signaling mediation by receptors
of the TNF family, was also recruited to this complex after viral
infection (Figures 3A and 3B), as were FADD (also known as
MORT1) and TRADD, two other adaptor proteins known to asso-
ciate with receptors of the TNF family, and NEMO, an adaptor
protein mediating NF-kB activation by these receptors (Fig-
ure S3B). Subcellular fractionation revealed that the virus
induced recruitment of both caspase-8 and RIP1, along with
TANK, to the mitochondria, the site of assembly of the RIG-I
complex (Figure 3C; Figure S3C).
To identify the protein(s) in the RIG-I complex that bind cas-
pase-8, we coexpressed individual components of this complex
with caspase-8 and assessed their association. Figures 3D and
3E show that caspase-8 bound to overexpressed RIG-I. Such
binding was observed both in cells transfected with wild-type
caspase-8 (Figure 3D) and in cells expressing the enzymatically
inactive C360S mutant, but not in cells overexpressing caspase-
8 molecules with two missense mutations that together abolish
the interaction of caspase-8 with FADD (FL122,123AA) (Fig-
ure 3E; Yang et al., 2005). In vitro synthesized caspase-8 and
RIG-I were also found to associate, suggesting that they bind
directly to each other (Figure S3D). Caspase-8, but not its
(FL122,123AA) mutant, also bound to a RIG-I fragment corre-
sponding to its CARD-domain region (Figure 3F). Association
of caspase-8 with either full-length RIG-I or its CARD-containing
fragment induced degradation of the two latter proteins. This
degradation could be blocked by a proteasomal inhibitor (Fig-
ure 3G). Overexpressed MAVS also coimmunoprecipitated
with caspase-8, whereas IRF3, although also found in the RIG-
I complex, did not. Unlike the binding of caspase-8 to RIG-I,
however, its binding to MAVS was not compromised by the
FL122,123AA mutations in caspase-8, nor did it induce MAVS
degradation (Figure S3E).Immunity 34, 340–351, March 25, 2011 ª2011 Elsevier Inc. 341
Figure 1. Caspase-8 Knockdown by a Caspase-8-siRNA-Expressing Lentivirus Causes Arrest of Cell Proliferation
(A) Arrest of proliferation of human FS11 cells (left) and of SV80 cells (right) upon caspase-8 knockdown. Inserts show themicroscopic appearance of cells, 5 days
after infectionwith control (top) or caspase-8 siRNA-expressing (bottom) lentiviruses, and immunoblot analyses of caspase-8 expression in these cells on that day.
(B) Kinetics of induction of the IFN-response gene IFI6. Real-time PCR assay of IFI6 mRNA expression in SV80 cells is shown at different times after their infec-
tion with the caspase-8 and control siRNA-expressing lentiviruses. In all diagrams presented in this study, bars correspond to mean values and ranges of data
obtained in two independent experiments in each case.
(C) Kinetics of IRF3 and STAT1 activation. Lentivirus expressing caspase-8 siRNA was added to SV80 cells that express caspase-8 with a mutation that renders
them unresponsive to the siRNA (right) or on SV80 cells expressing the ‘‘empty’’ control virus (left). Shown are immunoblots of the cellular IRF3 dimers and
monomers, separated by employing native gel electrophoresis, and of phosphorylated STAT1 and caspase-8, separated by SDS-PAGE.
(D) IRF3 knockdown rescues SV80 cells from the arrest of proliferation after caspase-8 knockdown. Curves depict the proliferation of cells preinfected with
control and caspase-8 siRNA-expressing lentiviruses and further transfected with control and IRF3 siRNA. Shown in the inset are immunoblots of IRF3
5 days after siRNA transfection.
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Processing of RIP1 Downstream of Asp-324
Immunoblot analysis of RIP1 in SeV-infected cells revealed that
the infection resulted in generation of a short form of RIP1with an
apparent molecular weight of about 38 kDa (Figure 4A). This form
could not be discerned in cells deficient in caspase-8 and its
amount was greatly reduced when caspase-8 was knocked
down (Figure 4A). Its generation could be regained in caspase-
8-deficient cells by reconstitution of the cells with wild-type
caspase-8, but not with the enzymatically inactive caspase-8
C360S mutant (Figure 4B), and could be blocked by an inhibitor
of caspase-8 (Figure 4C). Caspase-8 has been shown to cleave
RIP1 downstream of Asp-324 (Lin et al., 1999). As shown in Fig-
ure 4D, mutation of this residue abolished the generation of the
38 kDa fragment in response to SeV infection, confirming that
this short form of RIP1 corresponds to a product of its cas-
pase-mediated cleavage.
The 38 kDa fragment was also detectable in the RIG-I complex
isolated from caspase-8-expressing cells, though not in the
complex isolated from cells deficient in caspase-8 (Figure 5A).
Its relative amount in the RIG-I complex was much greater
than in the whole cell lysate, suggesting that cleavage of RIP1
occurs within this complex.SeV Infection Induces Ubiquitination of RIP1 at Lys-377
Although lacking the 38 kDa RIP1 fragment, the RIG-I complexes
isolated from caspase-8-deficient cells included some high-
molecular-weight forms of RIP1 that were not readily discernible
in the complexes isolated from normal cells (Figure 5A). Such
modified forms were also observed upon immunoblot analysis
of RIP1 in whole lysates of SeV-treated cells. Their amounts in
caspase-8-deficient cells and in cells expressing the enzy-
matically inactive caspase-8 mutant (C360S) were markedly
higher than in cells expressing the wild-type enzyme (Figures
5B and 5C).
Immunoblot analyses with pan-ubiquitin antibodies and anti-
bodies specific to lysine 63 (K63)-linked polyubiquitin chains
indicated that SeV infection induced conjugation of polyubiquitin
chains to RIP1 (Figure 5C) and that the ubiquitin molecules in
these chains are at least partly K63 linked (Figure 5D). The higher
accumulation of ubiquitinated RIP1 in SeV-infected caspase-
8-deficient cells suggested that RIP1 ubiquitination and RIP1
cleavage are inversely coupled. To test this notion, we reconsti-
tuted RIP1-deficient MEFs with wild-type RIP1, or with the
D324A RIP1 mutant, which, as shown above, was not cleaved
in response to SeV infection. In view of reported evidence that
TNF dictates conjugation of polyubiquitin (which is at least partly
K63 linked) to Lys-377 in RIP1 (Ea et al., 2006; Li et al., 2006;
Wu et al., 2006), we also reconstituted the RIP1-deficient
MEFs with RIP1 bearing a Lys-377 mutation. As shown in Fig-
ure 5C, in cells expressing the D324A mutant, ubiquitinated
RIP1 accumulated to a markedly greater extent than in cells ex-
pressing the wild-type protein. In contrast, no ubiquitination of(E) Light and fluorescence microscopy of SV80 cells 5 days after their infection w
that also expressed GFP. Cells shown in the right panels ectopically express cas
caspase-8 in the cells 5 days after lentivirus infection is shown at the bottom. Unle
results of at least three independent experiments.RIP1 was detectable in cells expressing the RIP1 (K377R)
mutant. Thus, ubiquitination of RIP1 in response to SeV infection
is counteracted by caspase-8-mediated cleavage of RIP1. The
findings further suggested that, as with TNF, the conjugation of
polyubiquitin to RIP1 in response to SeV infection occurs at
Lys-377 or at least depends on the occurrence of a lysine residue
at this site. Notably, the K377R mutation of RIP1 also prevented
generation of the 38 kDa cleaved product of the protein upon
SeV infection (Figure 5C, bottom), suggesting that ubiquitination
of RIP1 at Lys-377 is required for RIP1 processing by caspase-8.Ubiquitination of RIP1 at Lys-377 Facilitates Induction
of IRF3 Phosphorylation by SeV Infection
As opposed to the enhancement of SeV-induced IRF3 activation
in cells deficient in caspase-8, cells lacking RIP1 exhibited
reduced IRF3 activation and reduced induction of IRF3-depen-
dent genes in response to SeV infection (Figure 6A; Balachan-
dran et al., 2004). RIP1 deficiency had no effect, however, on
the virus-induced activation of NF-kB (Figure S4A). A similar
extent of reduction in IRF3 activation was also observed in cells
deficient in FADD or TRADD (Figure S4B; Balachandran et al.,
2004; Michallet et al., 2008).
Activation of IRF3 by SeV infection in cells expressing the
D324A RIP1mutant was substantially more effective than in cells
expressing wild-type RIP1. In contrast, in cells expressing the
K377R RIP1 mutant, virus-induced IRF3 activation was severely
impaired. Unlike in cells expressing wild-type RIP1, the cells
expressing either of the RIP1 mutants showed no increase in
virus-induced IRF3 activation after caspase-8 knockdown in
them (Figure 6B). These findings suggest that RIP1 ubiquitination
at Lys-377 is required for effective RIG-I-mediated signaling for
IRF3 activation and that the cleavage of RIP1 by caspase-8
largely accounts for the negative effect of caspase-8 on this
signaling.
To test these notions further, we examined the impact of the
above mutations of RIP1 on its function in transient transfection
tests. Activation of an ISRE-controlled promoter reporter by SeV
infectionwas enhanced by overexpression of wild-type RIP1 and
was enhanced even further by expression of the D324A RIP1
mutant, whereas expression of the K377R RIP1 mutant resulted
in much lower enhancement (Figure 6C). These differences in
promoter activation correlated with differences in effectiveness
of generation of IRF3 dimers (Figure 6D).
To explore themechanisms underlying thesemutation effects,
we compared the dynamics of SeV-induced assembly of the
RIG-I complex in cells expressing the different RIP1 mutants.
In cells deficient in RIP1, association of the various components
of this complex was weaker and shorter lived. Some of the
components seemed not to be recruited to the complex at
all (Figure 6E). In cells expressing the RIP1 K377R mutant,
RIP1 itself was effectively recruited to RIG-I (Figure S4C).
However, the extent of association of various other components
of this complex and the rate of decay of the resulting complexith control (left) or caspase-8 siRNA-expressing lentiviruses (middle and right)
pase-8 cDNA mutated to make it unresponsive to the siRNA. Immunoblots of
ss otherwise stated, all the data presented in this publication are representative
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type cells (Figure 6E). In contrast, in cells expressing the ‘‘non-
cleavable’’ D324A RIP1 mutant, both the effectiveness and the
duration of the association were greatly increased (Figure 6E).
Similar to this effect of the RIP1 D324A mutation, deficiency of
caspase-8, which likewise results in lack of cleavage of RIP1,
enhanced the stability of the RIG-I complex, as reflected in pro-
longed association of TBK1 with RIG-I (Figure S4D).
To evaluate the contribution of the 38 kDa C-terminal fragment
of RIP1 to the impact of caspase-8 on RIG-I signaling, we exam-
ined the effect of overexpression of this fragment on cell
response to SeV infection. Such overexpression dramatically
compromised the virus-induced assembly of the RIG-I complex,
as well as activation of IRF3 and of the IRF3-dependent ISRE-
controlled promoter (Figures 6F and 6G), while having no effect
on the virus-induced activation of NF-kB (Figure S4E).
DISCUSSION
Caspase-8 can serve, even within a single cell, functions that are
varied and even antagonistic in nature (BenMoshe et al., 2008b).
The only function of which we have detailed molecular knowl-
edge is the triggering of cell death by receptors of the TNF family.
The present study showed that caspase-8 also restricted the
induction of antiviral genes by viral RNAs and shed light on the
mechanisms for this nonapoptotic function.
Caspase-8 and RIP1 were both shown here to be recruited to
the mitochondria-associated RIG-I complex, where they serve
antagonistic roles. RIP1 apparently facilitates association of
some other components of the RIG-I complex by binding to
them, and this function is augmented by RIP1 ubiquitination.
One of these components of the RIG-I complex is probably
NEMO. This adaptor protein is capable of binding directly to
RIP1 (Zhang et al., 2000), and its binding is fortified by interaction
of a ubiquitin-binding motif in NEMO, which has been shown to
be crucially involved in RIG-I signaling (Zeng et al., 2009), with
the polyubiquitin chain conjugated to RIP1 Lys-377 (Ea et al.,
2006; Li et al., 2006; Wu et al., 2006). Consistently, we found
that recruitment of NEMO to the RIG-I complex was decreased
in cells expressing RIP1 molecules whose ubiquitination site
was mutated and was abolished in cells lacking RIP1.
Binding of RIP1 to the RIG-I complex and its subsequent ubiq-
uitination seem also to play decisive roles in the recruitment and
function of caspase-8 there. In RIP1-deficient cells, caspase-8
was not recruited, whereas in cells that expressed the ‘‘nonubi-
quitinable’’ K377R RIP1 mutant, caspase-8 was recruited but
was incapable of cleaving RIP1. The mechanisms underlyingFigure 2. Caspase-8 Deficiency Facilitates IRF3 Activation but Not Act
(A) Real-time PCR assessment of the expression of the specified IFN-response g
or infection with SeV. Comparison of the expression in wild-type cells and in cells r
siRNA oligonucleotides.
(B) Luciferase reporter tests for activation of the IRF3-dependent ISRE-controlled
control and caspase-8 knockdown HEK293T cells with the indicated doses of S
(C) IRF3 and IkB phosphorylation in the indicated cells in response to SeV infection
In all tests, phosphorylation of serine 396 in IRF3 and of serines 32 and 36 in IkB
(D) Effect of conditional deletion of Casp8 in hepatocytes on IRF3 activation by
phosphorylation and translocation to the nuclei and immunoblot analysis of IRF3 p
tocyte-specific deletion ofCasp8 (Alb-Cre F/-) at various times after SeV injection
mice. Immunostained liver sections were inspected and photographed under a Nthis dependence remain to be clarified. In vitro, ubiquitination
of RIP1 is not required for its caspase-mediated cleavage (Lin
et al., 1999) and might even interfere with its association with
caspase-8 (Legarda-Addison et al., 2009). Moreover, RIP1
does not bind caspase-8 and is therefore unlikely to play direct
role in the recruitment of the latter to the RIG-I complex. Instead,
caspase-8 binds to FADD (Wallach et al., 1999) and, as shown in
this study, probably also to RIG-I and MAVS.
Caspase-8 might affect other components of the RIG-I
complex in addition to RIP1. One of those might be RIG-I itself,
whose proteasomal degradation was shown here to be facili-
tated by overexpression of caspase-8. These effects might
also contribute to the inhibitory effect of caspase-8 on RIG-I
signaling. However, the substantially weakened effect of cas-
pase-8 deficiency on RIG-I signaling when RIP1-mediated
cleavage by caspase-8 was prevented suggests that this
cleavage is the predominant cause of the suppression of RIG-I
signaling by caspase-8.
The finding that the ubiquitin molecules in the chains conju-
gated to RIP1 are at least partly K63 linked is consistent with
the idea that this ubiquitination serves some signaling-regulatory
role, distinct from the proteasomal degradation dictated mainly
by conjugation of K48-linked polyubiquitin chains. A late
decrease in RIP1 that we observed after SeV infection of cas-
pase-8-deficient cells raised the possibility that at a certain
time after virus infection, caspase-8 deficiency also facilitates
K48-linked ubiquitination of RIP1. The ubiquitin ligase(s) medi-
ating RIP1 ubiquitination within the RIG-I complex remains to
be identified. It might well be cIAP1, which appears to serve
this role in the TNF-receptor complex and which we found also
recruited to the RIG-I complex.
The dual functional consequence of RIP1 ubiquitination—
enhancement of the assembly of the RIG-I complex and trig-
gering of its own cleavage—allows the coordinated effects of
RIP1 and caspase-8 to exert a unique kind of impact on RIG-I
signaling. Other regulators of the function of this complex act
in a unimodal fashion—they either enhance or inhibit it. In
contrast, because the arrest of RIG-I signaling by the coordi-
nated action of RIP1 and caspase-8 depends on the same
change in RIP1 as the one that maximizes its contribution to
RIG-I signaling, the combined effect of these two proteins is
bimodal, namely initial enhancement followed by arrest. Both
caspase-8 and RIP1 are ubiquitously expressed in cells. It
seems, therefore, that their combined effect on RIG-I signaling
serves not for inducible suppression or enhancement of the
signaling, but rather as a constitutive built-in module for restrict-
ing its duration without compromising its initiation. At the sameivation of NF-kB by SeV Infection
enes in the indicated cells as a consequence of their transfection with poly(I:C)
endered deficient in caspase-8 either byCasp8 knockout or by knockdownwith
promoter and of anNF-kB-dependent promoter, assayed 12 hr after infection of
eV.
. Normal cells are compared to cells with caspase-8 knockdown, as indicated.
a were examined with specific antibodies.
SeV infection in vivo. Top and middle, immunohistochemical analysis of IRF3
hosphorylation in the livers of control mice (Alb-Cre F/+) and of mice with hepa-
. Bottom, immunoblot analysis of IRF3 phosphorylation in the lungs of the same
ikon ECLIPSE E600 fluorescence microscope at a magnification of 3100.
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Figure 3. Caspase-8 and RIP1 Are Recruited to the RIG-I Complex upon Viral Infection
(A and B) Immunoblot analysis of coimmunoprecipitation of the indicated proteins with caspase-8 or MAVS in HeLa cells after SeV infection.
(C) Immunoblot analysis of the recruitment of caspase-8 and RIP1 to themitochondria after SeV infection. Quantities of the indicated proteins in themitochondrial
and cytoplasmic fractions are compared at various times after infection of MEFs with SeV. LDH and TOM20 served as markers for the presence of cytoplasmic
and mitochondrial proteins, respectively, in the tested fractions.
(D–F) Overexpressed caspase-8 binds to RIG-I. Assessment of the coimmunoprecipitation of caspase-8 (D) or its enzymatically inactive C360S mutant and
FL122,123AA mutant with RIG-I (E), and with its CARD-domain containing N-terminal 284 amino acid fragment (CARDRIG-I; F), from lysates of HEK293T cells
transiently overexpressing the proteins. Because of the inefficient expression of the C-terminal part of RIG-I (residues 289–925) in transfected cells, similar
assessment of its association with caspase-8 was not possible. In the experiment depicted in (D), triggering of cell death by a high cellular content of enzymat-
ically active caspase-8 was avoided by use of the pBabe-puro vector to express the enzyme at relatively low levels.
(G) Overexpression of caspase-8 in HEK293T cells facilitates degradation of coexpressed RIG-I (left), which could be blocked by a proteasomal inhibitor (MG132,
applied at 50 mM for 6 hr before cell lysis; right).
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modulation of signaling by additional proteins. It might, for
example, enable caspase-8-inhibitory molecules such as cFLIPs
(Wallach, 1997) to facilitate signaling, or allow proteins that
promote degradation of RIP1 or its polyubiqutin chains, such
as A20 (Wertz et al., 2004), to attenuate it.
The prevalence of proteins that participate in TNF receptor
signaling in the RIG-I complex is intriguing. It suggests that these
two receptors, although occurring in different subcellular346 Immunity 34, 340–351, March 25, 2011 ª2011 Elsevier Inc.compartments and serving different functional roles, share
some common mechanisms of action. There are indeed
a number of similarities between the interaction of RIP1 with cas-
pase-8 in the RIG-I complex and the way these two proteins
interact when signaling in response to TNF. Gene activation by
TNF through stimulation of NF-kB is largely mediated by the
binding of RIP1 to NEMO (Kelliher et al., 1998; Zhang et al.,
2000). This binding too is facilitated by the binding of NEMO to
a polyubiquitin chain anchored to Lys-377 in RIP1, and in this
Figure 4. Caspase-8 Mediates Cleavage of RIP1 after Virus Infection
(A) Immunoblots of RIP1 and its short form (38 kDa) at various times after SeV infection.
(B) Immunoblots of RIP1 and of the RIP1 38 kDa form induced by SeV in Casp8/ MEFs reconstituted with wild-type human caspase-8 and with the enzymat-
ically inactive C360S caspase-8 mutant.
(C) Assessment of the effect of the caspase-8 inhibitor Z-IETD-FMK (20 mM for 6 hr) on generation of the RIP1 38 kDa form in SeV-infected HeLa cells.
(D) Immunoblots of RIP1 and of the RIP1 38 kDa form induced by SeV in Rip1/ MEFs reconstituted with wild-type human RIP1 or its D324A mutant.
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2006; Wu et al., 2006). As with the RIG-I complex, activation
of caspase-8 by the TNF-receptor complex leads to cleavage
of RIP1 at Asp-324, and this cleavage, as well as the impact of
the resulting 38 kDa RIP1 fragment on the signaling complex,
mitigate signaling (Lin et al., 1999). It would be interesting to
find out whether the ubiquitination of RIP1 affects its cas-
pase-8-mediated cleavage in TNF signaling as well. Despite
these similarities, however, the eventual consequences of cas-
pase-8-RIP1 interaction in these two cases are very different.
When induced by TNF, RIP1 cleavage by caspase-8 results in
arrest of the activation of antiapoptotic genes and thus facili-
tates caspase-8-mediated cell death induction. RIP1 cleavage
by caspase-8 in response to RIG-I activation also results in
arrest of gene activation. We addressed its effect on activation
of IRF3, but it might also restrict the activation of some other
transcription factors in this pathway. In this case, however,
this restriction does not lead to cell death. During the postinfec-tion period over which we studied the impact of caspase-8 on
the response to viral infection, we could not discern any signs
of death induction (such as processing of caspase-3 or of poly-
(ADP-ribose) polymerase or enhanced binding of annexin-V to
the cells). More prolonged infection of cells by high doses of
SeV does lead to death. However, its induction in cells that
express caspase-8 is not higher than in caspase-deficient cells
(data not shown), which appears to contraindicate a role for
capase-8 activation within the RIG-I complex in this death
process.
As mentioned above, within the TNF-receptor complex RIP1
serves a prominent role in NF-kB activation. Surprisingly,
although the RIG-I complex is also believed to signal NF-kB acti-
vation, we found that deficiency of either RIP1 or caspase-8 had
no effect on the activation of NF-kB by SeV infection. It remains
to be determined whether this lack of effect reflects differential
involvement of the two proteins in the activation of IRF3 and
NF-kB by the RIG-I complex or a prominent involvement ofImmunity 34, 340–351, March 25, 2011 ª2011 Elsevier Inc. 347
Figure 5. SeV Infection Induces RIP1 Ubiquitination at Lys-377
(A) Immunoblots of RIP1, its 38 kDa fragment, and a high-molecular-weight form of RIP1 (asterisk), coimmunoprecipitated with TANK antibodies from normal and
caspase-8-knockdown MEFs and HeLa cells.
(B) Immunoblots of RIP1 in whole cell lysates at different times after virus application to Casp8/ MEFs and to Casp8/ MEFs reconstituted with wild-type
human caspase-8 or with its enzymatically inactive C360S mutant. Lines within the figure denote the borders between remote parts of the original gel that
were digitally merged.
(C) Immunoblots of RIP1 and of ubiquitin moieties conjugated to it in Rip1/MEFs reconstituted with wild-type human RIP1 or with its D324 or K377R mutants.
RIP1 was enriched by its immunoprecipitation from SDS-denatured cell lysates at various times after infection of the cells with SeV, and was then subjected to
immunoblot analysis with antibodies against ubiquitin (top) or against RIP1 (bottom).
(D) Assessment of the conjugation of K63-linked ubiquitin moieties to RIP1 molecules recruited to the RIG-I complex. To isolate proteins to which K63-linked
polyubiquitin chains were conjugated, proteins that were immunoprecipitated with MAVS antibodies from SeV-infected MEFs were denatured in a buffer con-
taining 6M urea, diluted 25-fold with lysis buffer, and incubated with a 1:1 mixture of two K63-specific polyubiquitin antibodies (Apu3 and HWA4C4). The isolated
proteins were then subjected to immunoblot analysis via antibodies against RIP1.
Immunity
Caspase-8 Controls RIG-I Signals via RIP1 Cleavagemechanism(s) independent of the RIG-I complex in NF-kB
activation by this virus.
Restrictions of the duration and extent of innate immune
response mechanisms are major determinants of their degree
of pathogen-versus-host specificity. When such restriction fails,
the innate response might turn out to cause more harm than
benefit to the host. As demonstrated here by the dramatic arrest
of the proliferation of cells in which caspase-8 expression was
knocked down by means of a viral vector, relief of the restriction
of RIG-I signaling by caspase-8 may interfere with the normal
function of the host cell. Besides intensifying the response of348 Immunity 34, 340–351, March 25, 2011 ª2011 Elsevier Inc.cells to viruses, deficiency in the restriction of cellular response
to PRRs might also result in excessive impact of endogenous
activators of these receptors and, as a consequence, in chronic
sterile inflammation (Beutler, 2004). When we assessed the
various tissue-specific roles of caspase-8 in transgenic mouse
models, we noticed that in several tissues, conditional deletion
of Casp8, or expression of an enzymatically inactive allele of
the enzyme along with an active allele, results in chronic inflam-
mation (Ben Moshe et al., 2007; Kovalenko et al., 2009; data not
shown). Detailed analysis of the mechanism underlying the
inflammation that results from deletion ofCasp8 in the epidermis
Figure 6. SeV-Induced IRF3 Activation Is Facilitated by RIP1 and by Its Ubiquitination and Antagonized by Caspase-8-Mediated RIP1
Processing
(A) Induction of CXCL10, an IRF3-dependent gene, and of IRF3 phosphorylation (inset), in SeV-infected normal and RIP1 knockdown HeLa cells.
(B) Immunoblot of SeV-induced phospho-IRF3 in RIP1 knockout MEFs reconstituted with wild-type RIP1 or with its ‘‘noncleavable’’ D324A or ‘‘nonubiquitinable’’
K377R mutants, as well as after knockdown of caspase-8 in these cells. Quantification of the data is shown in the lower panel.
(C and D) Effect of transient overexpression of RIP1 and of its indicated mutants (in pBabe-puro vector) on SeV-induced IRF3 activation in HEK293T cells,
assessed by the ISRE luciferase reporter test (C) or by immunoblot analysis of IRF3 dimerization (D).
(E) Contribution of RIP1 to SeV-induced assembly of the RIG-I complex and impact of the indicated RIP1 mutations on the assembly. Coimmunoprecipitation of
the indicated proteins with TANK was assessed at different times after application of SeV to RIP1-deficient MEFs reconstituted with RIP1 or with its indicated
mutants or, as a control, with empty vector.
(F) Effect of transient overexpression of the 38 kDa C-terminal RIP1 (325–657) fragment in HEK293T cells on SeV-induced IRF3 activation, assessed by the ISRE
luciferase reporter test. Data are from an experiment that was performed twice with similar results.
(G) Effect of overexpression of the 38 kDa C-terminal RIP1 (325–657) fragment in HeLa cells on SeV-induced IRF3 phosphorylation and dimerization (left) and on
assembly of the RIG-I complex, assessed by determining the coimmunoprecipitation of TBK1, IRF3, and RIP1 with TANK (right).
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Immunity
Caspase-8 Controls RIG-I Signals via RIP1 Cleavagerevealed that this inflammation is correlated with chronic activa-
tion of IRF3 (Kovalenko et al., 2009). The excessive response of
caspase-8-deficient keratinocytes to endogenous and exoge-
nous stimuli of the RIG-I pathway (this study and Kovalenko
et al., 2009) might account for this activation.
The finding that caspase-8 is recruited to the RIG-I complex
and is activated there in a way that results in exclusive cleavage
of specific component(s) of this signaling complex provides
a clue to the mechanism by which caspase-8—an enzyme with
the capacity to trigger a full-blown apoptotic program—is also
capable of specific regulation of gene activation by viral nucleic
acids. Further analysis of the mechanism by which caspase-8 is
activatedwithin the RIG-I complex, aswell as theway inwhich its
substrate specificity within this complex is determined, might
yield mechanistic insights with general implications for the
various other nonapoptotic functions of caspases.EXPERIMENTAL PROCEDURES
Antibodies, Cells, and Mice
The antibodies, cells, and mice used to generate the cell lines utilized in this
study are described in Supplemental Experimental Procedures.
Mammalian Expression Vectors and Their Use for Expression
of Transfected Proteins
Constitutive expression of human caspase-8, human RIP1, and mutants
thereof in SV80 cells and in MEFs derived from mouse knockout strains
deficient in these proteins was established with the retroviral Phoenix-
Helper-dependent pBabe system (Cell Biolabs). In all cases we used entire
pools of infected cells without subcloning them. The green fluorescent protein
(GFP)-expressing FUGW lentiviral vector (Lois et al., 2002) was a kind gift from
C. Lois from the laboratory of D. Baltimore at Caltech.
Proteins were ectopically expressed in HEK293T and HeLa cells by their
transient transfection with pcDNA3-, pCruz-, or, when indicated, pBABE-
puro-based constructs, with the JetPEI transfection reagent (Gene Therapy
Systems) according to the manufacturer’s instructions.
RNA Interference
Transient knockdown of human IRF3, caspase-8, RIP1, FADD, or TRADD was
achieved by transfection of HeLa, HaCaT, SV80, and U2OS cells with 100 nM
of their respective ON-Target Plus siRNAs (Thermo Fisher Scientific) via Lipo-
fectamine 2000 (Invitrogen), as specified by the manufacturer. Transient
knockdown of mouse caspase-8 in keratinocytes was achieved by transfec-
tion of the cells with Accell siRNA duplex for mouse caspase-8 (Thermo Fisher
Scientific).
Constitutive knockdown of caspase-8 in SV80, FS11, and HaCaT cells (in
the experiments presented in Figure 1, Table S1, and Figures S1A–S1G) was
achieved by infecting these cells with a GFP-expressing FUGW lentivirus
based on the FUGW vector, to which a cassette of H1 promoter upstream of
a caspase-8 siRNA-containing sequence (50-GAGCCTGCTGAAGATAATC-
30 ) was transferred from the pSUPER vector.
Immunoprecipitation and Immunoblotting
To assess the ubiquitination of RIP1 (Figures 5C), cells were lysed by boiling in
a buffer containing 1% SDS, 20 mM Tris-HCl (pH 7.5), 5 mM EDTA, and 1 mM
dithiothreitol, followed by dilution of the lysates 10-fold in a buffer containing
1%NP-40, 20 mM Tris-HCl (pH 7.5), 50 mMNaCl, and 5 mM EDTA and immu-
noprecipitation with RIP1 antibody. In all other tests, immunoprecipitation was
carried out after the cells had been extracted with a lysis buffer containing
20 mM Tris-HCl (pH 7.5), 50 mM NaCl, 0.5% NP-40, 4 mM EDTA, 0.1%
SDS, 0.5% sodium deoxycholate, 30 mM NaF, 1 mM sodium vanadate,
40 mM b-glycerophosphate, and 13 Complete Protease Inhibitor Cocktail
(Roche). In the experiment presented in Figure 5D, cell extraction was done
in the presence of 10 mM N-ethylmaleimide.350 Immunity 34, 340–351, March 25, 2011 ª2011 Elsevier Inc.In the immunoblot analyses, horseradishperoxidase-conjugatedanti-mouse
or anti-rabbit Ig antibodies were applied to detect the primary antibodies.
Blots were developed with the enhanced chemiluminescence SuperSignal
West Pico Chemiluminescent Substrate (Pierce) system according to the
manufacturer’s instructions.Native Polyacrylamide Gel Electrophoresis and Immunoblotting
Native PAGEwas performedwith 7.5%polyacrylamide gels as follows: The gel
was prerun for 30 min at 40 mA with 25 mM Tris and 192 mM glycine (pH 8.4),
with and without 1% deoxycholate in the cathode and anode chambers,
respectively. Samples in the native sample buffer (10 mg of protein in
62.5 mM Tris-HCl [pH 6.8], 15% glycerol, and 1% deoxycholate) were applied
to the gel and electrophoresed for 60 min at 25 mA. IRF-3 antibody was used
for immunoblotting.Phospho-IRF3 Immunohistochemistry
The livers of mice injected with SeV were fixed in 10% phosphate-buffered
formalin (pH 7.4), embedded in paraffin, and cut into 4 mm sections. The
sections were dehydrated and microwaved in 10 mM citrate buffer (pH 6.0)
for 10 min. Nonspecific binding sites were blocked by incubation for 1 hr in
normal horse serum followed by sequential incubation with anti-ph-IRF3 and
Cy-3-coupled secondary antibody.Luciferase Reporter Tests
HEK293T cells (4 3 105 cells) seeded in 6-well plates were transiently trans-
fected with the reporter plasmid (luciferase cDNA driven either by an ISRE-
controlled promoter, kindly donated by B.-Z. Levi, Technion, Haifa, or by
a promoter controlled by an NF-kB element of the minimal HIV enhancer)
and, when indicated, with the cDNA for the 38 kDa RIP1 fragment, with the Jet-
PEI transfection reagent. At the indicated times, the cells were lysed in 100 ml of
lysis buffer as described (Ausubel et al., 1996), and 25 ml aliquots were used for
the assay with D-luciferin (Promega) as substrate in a Lumac Biocounter
luminometer.SeV Infection and Poly(I:C) Transfection
SeV (Cantell strain) was obtained from Charles River Laboratories. Unless
otherwise indicated, the virus was applied to cells at a concentration of 150 he-
magglutinating (HA) units/ml. For assessment of the virus effect in vivo, mice
were given a single intravenous injection of 200 ml of 800 HA units/ml SeV.
They were then killed at various time points and their organs were collected
for further analysis.
Poly(I:C) (Sigma-Aldrich) was transfected into cells at a concentration of
5 mg/ml with Lipofectamine 2000 (Invitrogen).Isolation of Mitochondria from Cultured Cells
Cells were suspended in isotonic HIM buffer (200 mM mannitol, 70 mM
sucrose, 1 mM EGTA, and 10 mMHEPES [pH 7.5]) and homogenized by being
passed 20 times through a 25-gauge needle. Nuclei and intact cells were
removed by centrifugation at 1203 g for 5 min. The supernatants were centri-
fuged at 10,000 3 g for 10 min to obtain the mitochondria-enriched and cyto-
solic (supernatant) fractions.Microarray Hybridization and Real-Time PCR Analyses
For mRNA-expression profiling of SV80 cells, Whole Human Genome
Microarrays (44K format; Agilent Technologies) were used as described
(Kovalenko et al., 2009). For real-time PCR analyses, we used TaqMan
Assays-on-Demand (Applied Biosystems) on an ABI7500 real-time PCR
system, as described (Kovalenko et al., 2009).ACCESSION NUMBERS
The microarray data are available in the Gene Expression Omnibus (GEO)
database (http://www.ncbi.nlm.nih.gov/gds) under the accession number
GSE23363.
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